Want to join the conversation?
$NTAP said product revenue was $660MM in the quarter and for the first time in several quarter was essentially flat on a YoverY basis. The company expects the growth of its strategic solutions to improve the overall product revenue growth trajectory over the course of FY17.
Keep your eyes on $FLXN. This one could ascend rapidly. Great time to buy your favourite bio stocks. Make more $$$
$CRM on the pop today.. big bubble.
Slumping and down the drain... $HDSN. Flush out your holdings !
$KITE I am loving this one... really flying like a kite today :-)